製品詳細
Synonyms
CTSS, Cathepsin S
Source
Human Cathepsin S, His Tag (CTS-H52H9) is expressed from human 293 cells (HEK293). It contains AA Gln 17 - Ile 331 (Accession # P25774-1).
Predicted N-terminus: Gln 17
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 37.7 kDa. The protein migrates as 38-42 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
The protein was designed as the pro-form (AA 17-331). However, due to the inherent autoprocessing nature of Cathepsin S, the activation peptide is partially cleaved during expression and purification. Consequently, the final product coexists as a mixture of the pro-form (AA 17-331) and the mature form (AA 115-331).
The protein is designed as a dimer.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>90% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
Formulation
Supplied as 0.2 μm filtered solution in 12.5 mM MES, 75 mM NaCl, pH6.5 with glycerol as protectant.
Contact us for customized product form or formulation.
Shipping
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 3 months under sterile conditions.
ACRO Quality Management System
お客様はこちらも閲覧
データ表示
SDS-PAGE

Human Cathepsin S, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.
SEC-MALS

The purity of Human Cathepsin S, His Tag (Cat. No. CTS-H52H9) is more than 95% and the molecular weight of this protein is around 70-92 kDa verified by SEC-MALS.
Report
Bioactivity
Measured by its ability to cleave the fluorogenic peptide substrate, McaRPKPVENvalWRK(Dnp)NH2. The specific activity is >1200 pmol/min/µg, as measured under the described conditions (QC tested).
Protocol
ユーザーレビュー コメントを投稿

バックグランド
最新の進展
- 英語名:
Cathepsin S
- カテゴリ:
- 市販の医薬品数:
0 詳細
- 治験医薬品数:
1 詳細
- 最新の開発ステージ:
Phase 1 Clinical
メールアドレス
order.jp@acrobiosystems.comお問い合わせ
グローバル:+1 800-810-0816(Toll Free)



















